Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bradykinin receptor types and B2 subtypes

D Regoli1, F Gobeil, Q T Nguyen

  • 1Department of Pharmacology, Medical School Université de Sherbrooke, Québec, Canada.

Life Sciences
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice.

Neuroscience·2013
Same author

Therapeutic options in inflammatory bowel disease: experimental evidence of a beneficial effect of kinin B1 receptor blockade.

British journal of pharmacology·2008
Same author

Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.

British journal of pharmacology·2008
Same author

Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.

Neuropeptides·2007
Same author

Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2.

The journal of peptide research : official journal of the American Peptide Society·2005
Same author

Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.

Naunyn-Schmiedeberg's archives of pharmacology·2004

Researchers identified two bradykinin B2 receptor subtypes, finding they differ between species. Rabbit and human B2 receptors appear similar, distinct from rat and guinea pig subtypes.

Area of Science:

  • Pharmacology
  • Receptor Subtyping
  • Kinin Receptors

Background:

  • Bradykinin (BK) and its analogues are crucial for understanding B2 receptor function.
  • Previous studies indicated potential differences in B2 receptor pharmacology across species.

Purpose of the Study:

  • To identify bradykinin B2 receptor subtypes using various agonists and antagonists.
  • To determine if pharmacologic B2 receptor subtypes are species-dependent.

Main Methods:

  • Testing isolated organs and vessels from rat, guinea pig, rabbit, and human.
  • Characterizing receptor responses to agonists and antagonists, including competitive and non-competitive inhibitors.
  • Analyzing agonist potency and antagonist affinities.

Related Experiment Videos

Main Results:

  • B2 receptors in rat and guinea pig tissues exhibit similar pharmacology, distinct from rabbit and human.
  • Agonist potency order varies between rabbit and guinea pig B2 receptors.
  • Antagonist affinities differ significantly, with some showing species-specific activity.

Conclusions:

  • The study confirms the existence of at least two distinct B2 receptor subtypes.
  • Evidence suggests that B2 receptor subtypes are species-dependent.
  • The B2 receptor subtype in rabbits is pharmacologically similar to that in humans.